Free Trial
→ We recommended Palantir in 2021, now we’re recommending this... (From Behind the Markets) (Ad) Free DNTH Stock Alerts

Dianthus Therapeutics (DNTH) SEC Filings & 10K Form

Dianthus Therapeutics logo
$23.80 +0.76 (+3.30%)
(As of 12/20/2024 05:16 PM ET)
Compare

Recent Dianthus Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
12/03/2024
8:19 PM		Avidity Partners Management LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13D/A
11/22/2024
3:41 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
11/14/2024
4:47 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:48 PM		5AM Partners VII, LLC (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13G/A
10/24/2024
1:02 PM		BlackRock, Inc. (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13G
10/21/2024
3:19 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form RW
10/09/2024
11:15 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form EFFECT
10/09/2024
11:15 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form EFFECT
10/01/2024
7:00 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:31 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/01/2024
3:36 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/18/2024
4:38 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
4:32 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
7:45 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Viridian, LLC (Filed by)
Form SC 13D/A
08/08/2024
3:26 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/06/2024
7:00 AM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
6:57 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:58 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Lawton Alison Frances (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:58 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
McGeorge Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:58 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:59 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Soteropoulos Paula (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:02 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Violin Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:03 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Garcia Marino (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:04 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Savitz Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:04 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Randhawa Simrat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:05 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:05 PM		CARR EDWARD (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:24 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 424B3
05/28/2024
4:20 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:20 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
3:08 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
3:05 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form DEF 14A
04/11/2024
3:09 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form DEFA14A
04/11/2024
3:10 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form ARS
04/01/2024
5:34 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
Form SC 13D/A
04/01/2024
5:21 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
11:15 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form EFFECT
03/21/2024
4:02 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-1/A
03/21/2024
4:10 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/02/2024
3:32 PM		BCLS Fund III Investments, LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13G
01/31/2024
11:11 AM		Avidity Partners Management LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13D
This is the worst sign for the U.S. stock market in 50 years (Ad)

The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"

Click here to see Dan's new, urgent warning about the U.S. market for 2025.
01/24/2024
6:02 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
6:04 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
5:55 PM		Avidity Partners Management LLC (0001993910) (Reporting)
Avidity Partners Management LP (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Gregory Michael David (Reporting)
Meng Lei (Reporting)
Witzke David Roy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
4:26 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
Form SC 13D/A
01/22/2024
6:34 AM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
7:02 AM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
4:08 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:DNTH) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this win...
Behind the Markets | Sponsored
This Crypto Is Set to Explode in December
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
AI breakthrough about to upend industry
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...
Porter & Company | Sponsored
Your bank is lying to you.
You might think you have your money in a high-yield savings account, but do you really? The national average A...
MyBankTracker | Sponsored
MUST SEE: The most important video in the world right now?
If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...
InvestorPlace | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...
Crypto Swap Profits | Sponsored
Did You See Trump’s Bombshell Exec. Order 001?
Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...
Banyan Hill Publishing | Sponsored